Sonic Healthcare Ltd SHL
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SHL is a good fit for your portfolio.
News
-
Sonic Healthcare to Pay $132 Million for Swiss Lab Group
-
Sonic Healthcare 1st Half Net Profit Falls 47%
-
Sonic Healthcare Agrees US$150 Million Acquisition of Pathology Watch
-
Sonic Healthcare Annual Profit Falls 53% as Covid-19 Boost Ebbs
-
Synlab Sells Swiss Business to Sonic Healthcare for $167.5 Million
Trading Information
- Previous Close Price
- A$26.63
- Day Range
- A$26.42–26.95
- 52-Week Range
- A$25.72–36.40
- Bid/Ask
- A$26.53 / A$26.70
- Market Cap
- A$12.78 Bil
- Volume/Avg
- 1.0 Mil / 1.5 Mil
Key Statistics
- Price/Earnings (Normalized)
- 24.67
- Price/Sales
- 1.51
- Dividend Yield (Trailing)
- 3.94%
- Dividend Yield (Forward)
- 3.94%
- Total Yield
- 3.95%
Company Profile
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the U.K., the second largest in Belgium and New Zealand, and the third largest in the U.S. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 40% of group revenue in Australia and New Zealand, 25% in the U.S., and 35% in Europe.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Large Value
- Total Number of Employees
- 41,000
- Website
- https://www.sonichealthcare.com
Competitors
Valuation
Metric
|
SHL
|
HLS
|
DGX
|
---|---|---|---|
Price/Earnings (Normalized) | 24.67 | 2.47 | 15.98 |
Price/Book Value | 1.65 | 0.87 | 2.40 |
Price/Sales | 1.51 | 0.45 | 1.69 |
Price/Cash Flow | 11.08 | 2.67 | 11.12 |
Price/Earnings
SHL
HLS
DGX
Financial Strength
Metric
|
SHL
|
HLS
|
DGX
|
---|---|---|---|
Quick Ratio | 0.78 | 0.44 | 0.78 |
Current Ratio | 0.94 | 0.53 | 0.97 |
Interest Coverage | 5.95 | −13.26 | 7.31 |
Quick Ratio
SHL
HLS
DGX
Profitability
Metric
|
SHL
|
HLS
|
DGX
|
---|---|---|---|
Return on Assets (Normalized) | 4.07% | 0.10% | 7.33% |
Return on Equity (Normalized) | 7.01% | 0.23% | 15.76% |
Return on Invested Capital (Normalized) | 4.52% | 2.27% | 9.73% |
Return on Assets
SHL
HLS
DGX
Diagnostics & Research Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Lclqfbdz | Nbnb | $227.2 Bil | |
DHR
| Danaher Corp | Ytsdtkblqs | Dsdsq | $196.9 Bil | |
A
| Agilent Technologies Inc | Ksxzkhddx | Vbcny | $45.2 Bil | |
IDXX
| IDEXX Laboratories Inc | Lbxdzctxj | Kqbyrq | $44.9 Bil | |
IQV
| IQVIA Holdings Inc | Jgydcmh | Crxnbz | $42.8 Bil | |
MTD
| Mettler-Toledo International Inc | Mjzfgpqfn | Trbwkhs | $32.5 Bil | |
ICLR
| Icon PLC | Hbmxwfrw | Zrfwyn | $26.0 Bil | |
WAT
| Waters Corp | Sjcxqhjdd | Rddk | $21.1 Bil | |
LH
| Laboratory Corp of America Holdings | Fxfsyvpmg | Btxcdd | $17.8 Bil | |
ILMN
| Illumina Inc | Zpwdfccmq | Hkrylr | $17.7 Bil |